EPS was EUR 0.78 (0.30) and EPS excl. fair valuations (FV) was EUR 0.32 (0.09). Operating profit (IFRS) increased to EUR 839 (289) million including the positive impact from the valuation of biological assets. Strong cash flow from operations amounted to EUR 619 (436) million. Cash flow after investing activities was EUR 424 (223) million.
Operational EBIT increased to EUR 426 (118) million. Sales increased by 26.3% to EUR 2,719 (2,154) million.
Operational EBIT margin increased to 15.7% (5.5%). Q4/2021 (year-on-year)
Sales were EUR 10,164 (8,553) million. Operational EBIT more than doubled to EUR 1,528 (650) million. Year 2021 (year-on-year)
Operational ROCE excluding the Forest division increased to 20.4% (4.7%), and was clearly above the long-term target of more than 13%. The net debt to operational EBITDA ratio improved to 1.1 (2.3). The target is to keep the ratio below 2.0.
The News Highlights
- Launch of the Stora Enso Oyj Financial Statement 2021
- Check the latest News news updates and information about business, finance and more.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week